Process Development Senior Principal Scientist
Amgen Inc., California
Dr. Joseph Cohen is a Process Development Senior Principal Scientist at Amgen, specializing in the evaluation of immunogenicity, biological and safety impacts of drug product critical quality attributes. With expertise in protein-based biologics, cellular therapeutics, immunology, and cancer immunobiology, Dr. Cohen earned his BS in Biochemistry from the University of Tampa and his PhD from UCLA in the areas of brain tumor biology and therapy. Dr Cohen completed postdoctoral work at NIH in the areas of cancer immunotherapy and metastasis at the NCI in Bethesda. He has contributed to advancing our understanding of immunogenicity of biologics drug products, as well as cellular therapeutics for hematological and solid tumors at several institutions including John Wayne Cancer Institute and City of Hope.
Disclosure information not submitted.
Thursday, July 17, 2025
9:05 AM - 9:35 AM ET
Joint Session on the Relationship Between Impurities and Immunogenicity: Panel Discussion
Thursday, July 17, 2025
9:35 AM - 10:30 AM ET